Sanofi under antitrust probe as European Commission kicks off formal proceedings
The European Commission has launched a formal antitrust investigation into Sanofi's flu vaccine marketing campaigns.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The European Commission has initiated formal antitrust proceedings against the French pharmaceutical company Sanofi. The probe specifically targets the company's flu vaccine campaign.
Coverage from Reuters, Financial Times, and The Wall Street Journal emphasizes the launch of the probe by Brussels. MLex reports that Sanofi has been invited to settle the matter.
Future developments depend on the outcome of these formal proceedings and whether Sanofi reaches a settlement with the EU Commission.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 15h ago.
Quick answers
Who is conducting the antitrust probe?
The European Commission (Brussels).
What specific product is under investigation?
Sanofi's flu vaccine campaign.
Has Sanofi been offered a way to resolve the probe?
According to MLex, Sanofi has been invited to settle the probe.
Coverage (6)
- Sanofi invited to settle EU antitrust probe into flu vaccine MLex · 2d ago
- Vaccine denial: The Briefing for 26 June 2026 Global Competition Review · 2d ago
- EU Commission opens antitrust probe into Sanofi's flu vaccine campaign Reuters · 2d ago
- Brussels launches antitrust probe into French drugmaker Sanofi Financial Times · 2d ago
- Sanofi Probed by EU Over Flu Vaccine Marketing WSJ · 2d ago
- Sanofi under antitrust probe as European Commission kicks off formal proceedings Fierce Pharma · 2d ago
Topics
Related trends
EU proposes extending Ukrainian protection to 2028, limit men of fighting age
The EU proposes extending temporary protection for Ukrainians to 2028 while excluding new arrivals of military age.
Trump spoke with Live Nation CEO shortly before surprise Justice Department settlement, court filing reveals
A court filing reveals a conversation between former President Trump and Live Nation's CEO before a surprise settlement in an antitrust case.
Paramount-Warner Merger Reportedly Set To Clear EU Antitrust Hurdles
A massive entertainment merger between Paramount and Warner Bros. Discovery is reportedly nearing completion as EU antitrust hurdles clear.
Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS
The NHS will begin rolling out Teplizumab, a disease-modifying therapy designed to delay the onset of type 1 diabetes.
New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel
An FDA advisory panel has unanimously endorsed Moderna's first-of-its-kind mRNA-based seasonal influenza vaccine, mRNA-1010.